NetworkNewsBreaks

ThursdayAug 19, 2021 11:51 am

NetworkNewsBreaks – Immunic Inc. (NASDAQ: IMUX) Secures $45M in Underwritten Public Offering

Immunic (NASDAQ: IMUX) has announced the closing of an underwritten public offering of 4,500,000 shares of its common stock at a public offering price of $10.00 per share. According to the update, the company received total proceeds of $45 million from the offering, before deducting underwriting discounts and other expenses. Immunic intends to use net proceeds of the offering to fund the ongoing clinical development of its three lead product candidates, IMU-838, IMU-935 and IMU-856, as well as for other general corporate purposes. Roth Capital Partners acted as co-manager for the offering. To view the full press release, visit https://nnw.fm/mEuDE…

Continue Reading

ThursdayAug 19, 2021 11:45 am

NetworkNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) Co-Founder, CEO Featured on Bell2Bell Podcast

Mind Cure Health (CSE: MCUR) (OTCQB: MCURF), a leader in advanced proprietary technology and research for psychedelics, has announced that co-founder and CEO Kelsey Ramsden is featured on the latest episode of the Bell2Bell podcast. The Bell2Bell Podcast offers its listeners insightful interviews with executives of companies operating in fast-moving industries. During the episode, hosted by InvestorBrandNetwork’s Stuart Smith, Ramsden provided an overview of the company’s business model and also discussed the changing regulatory and social environments surrounding psychedelic-assisted therapy. She also talked about the company’s current focus: the development of a clinical-grade, evidence-backed, science-based, AI-driven tool to enable therapists…

Continue Reading

ThursdayAug 19, 2021 11:23 am

NetworkNewsBreaks – DSG Global Inc. (DSGT) Announces Upcoming Unveiling of the Sagitta(TM) EV

DSG Global (OTCQB: DSGT), an emerging global technology company with an array of interconnecting businesses in rapidly growing market sectors, today announced that Milpitas, California- based California Mobility Works (“CMW”) and Imperium Motors will host the unveiling of the Sagitta(TM) EV on Nov. 17, 2021, at the LA Auto Show. According to the update, the three-wheel, four-passenger Sagitta will impress the automotive world with its innovative styling and superb engineering. Setting a new standard for aesthetics, passenger and cargo space, range, and value, the Sagitta aims to dramatically expand the accessibility of environmentally responsible EV technology to a broad range…

Continue Reading

ThursdayAug 19, 2021 10:57 am

NetworkNewsBreaks – Kaival Brands Innovations Group Inc. (NASDAQ: KAVL) Featured in Equity Research Report

Kaival Brands (NASDAQ: KAVL), a company focused on growing and incubating innovative and profitable products into mature and dominant brands, was featured in a recent equity research report. The coverage, launched by Argus Research, an independent investment research firm, highlights innovative vaping and tobacco-free nicotine delivery solutions manufactured by Bidi (R) Vapor LLC, for which Kaival Brands is the exclusive global distributor. “In our view, Kaival Brands is well positioned to expand sales of BIDI (R) nicotine delivery products. The company launched the BIDI (R) Stick in the U.S. in early 2020 and plans to launch a second product, the…

Continue Reading

ThursdayAug 19, 2021 10:50 am

NetworkNewsBreaks – Cabaletta Bio Inc. (NASDAQ: CABA) Featured in Mizuho Securities Research Report

Cabaletta Bio (NASDAQ: CABA) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “Cabaletta's safety data from the second dose cohort at a dose of 100M DSG3-CAART cells in the DesCAARTes Phase 1 in mucosal pemphigus vulgaris continue to demonstrate no clinically relevant adverse events or DLTs observed during the 28-day monitoring period following infusion. We find today's announcement especially encouraging, as the data demonstrate the potential for persistent activity and dosing approaching that of oncology but without the need for preconditioning, which we believe makes the approach highly attractive for non-oncology…

Continue Reading

ThursdayAug 19, 2021 10:36 am

NetworkNewsBreaks – Green Hygienics Holdings Inc. (GRYN) Names Former J&J Director as New Chief Scientific Officer

Green Hygienics (OTCQB: GRYN), an innovative, technology-driven enterprise focused on the high-standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids, has announced that Dr. Francesca Serraino Fiory will serve as the company’s new chief scientific officer. In her new role, Fiory will manage product development, including GRYN’s multibrand portfolio, and oversee research and development efforts under TruLife Biotech, the company’s wholly owned subsidiary. In addition, she will head up partnerships with both academic institutions and research centers and will navigate the company across the global regulatory landscape. Fiory has worked for several major players in the…

Continue Reading

ThursdayAug 19, 2021 9:56 am

NetworkNewsBreaks – Nextech AR Solutions Corp. (OTCQB: NEXCF) (NEO: NTAR) (CSE: NTAR) (FSE: N29) Announces Integration of 3D, AR Ad Functionality with SNAP, Facebook and Instagram

Nextech AR Solutions (OTCQB: NEXCF) (NEO: NTAR) (CSE: NTAR) (FSE: N29), an emerging leader in augmented reality (“AR”) for eCommerce, AR learning applications, AR-enhanced video conferencing and virtual events, has integrated its next-generation ad technology with social media channels, including SNAP, Facebook and Instagram. This integration strengthens and broadens the company’s  3D/AR ad reach. Previously NexTech customers could tap into Google’s immense network, but with this new advancement, NexTech users can deliver 3D ads for other social media applications, including SNAP, Facebook and Instagram. This enhanced feature allows NexTech to leverage the full spectrum of audiences across the web and…

Continue Reading

ThursdayAug 19, 2021 9:32 am

NetworkNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American CYBN) Files Two International Patent Applications in Support of the Company’s Research Phase Programs

Cybin (NEO: CYBN) (NYSE American CYBN), a biotechnology company focused on progressing psychedelic therapeutics, has filed two additional international patent applications; these applications open the possibility for CYBN to obtain patent coverage in 153 countries and, if approved, allow the company to file future national applications into treaty member jurisdictions. The company filed the applications under the Patent Cooperation Treaty (“PCT”). One of the patent applications concerns a group of proprietary compounds that the company has identified as important for further evaluation toward selection as potential therapeutics. The other application regards claims and disclosures toward other proprietary novel psychedelic compounds, including…

Continue Reading

WednesdayAug 18, 2021 3:22 pm

NetworkNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Approval of Charter Amendment

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced that on Aug. 17, 2021, the stockholders approved an amendment to the company’s certificate of incorporation. The amendment, effective Aug. 17, 2021, increased the number of authorized shares of company common stock from 100,000,000 to 200,000,000. According to the update, the approval was granted at the special meeting of stockholders convened on Aug. 10, 2021, and adjourned to Aug. 17, 2021. To view the full press release, visit https://nnw.fm/X0qRt About Predictive Oncology Inc. Predictive Oncology operates through three segments…

Continue Reading

WednesdayAug 18, 2021 2:35 pm

NetworkNewsBreaks – Kura Sushi USA Inc. (NASDAQ: KRUS) Secures $57M in Underwritten Public Offering

Kura Sushi USA (NASDAQ: KRUS), a fast-growing technology enabled Japanese restaurant concept, has closed an underwritten public offering of 1,265,000 shares of its Class A common stock, which includes 165,000 shares per the full exercise of the over-allotment option granted to the underwriters. The company secured approximately $57 million in gross proceeds, with each of the shares sold at a public offering price of $45.00. Kura Sushi USA anticipates using proceeds from the offering for general corporate purposes, including capital expenditures, the repayment of the indebtedness outstanding under its existing revolving credit agreement with its parent company, working capital, as…

Continue Reading